
Semax
Heptapeptide Nootropic
Synthetic analogue of ACTH(4-10). Sequence conserved from the endogenous ACTH fragment. Semax is a short acth analogue presented as a freeze-dried solid with amber-glass packaging and argon-flushed headspace.
Synthesis uses Fmoc solid-phase chemistry with HBTU activation; crude peptide is precipitated in cold ether and polished by reverse-phase HPLC until purity floors at 99.05%. Every lot leaves the bench with ESI-TOF, LAL endotoxin, and residual-solvent data attached.
Lyophilised material is stable frozen at −20 °C. In aqueous solution, HPLC purity holds refrigerated for roughly two weeks; single-thaw only, no repeated freeze-thaw cycles.
- Sequence
- MEHFPGP
- Molecular weight
- 813.93 g/mol
- Purity (HPLC-MS)
- 99.05%
- Dose · fill
- 10 mg
- Lot number
- C-0312
- CoA date
- 2026-03-22
- Storage
- −20 °C · thaw once
- Shipping
- Cold-chain, 1-day overnight

Fig. — Amber borosilicate vial, argon-flushed, 10 mg fill.
- Lot
- C-0312
- Dose
- 10 mg
- In stock
- 96 vials
- Dispatch
- Within 24h
- Storage
- −20 °C · thaw once
Ships in 1–2 business days
Adjacent entries


PT-141

